BLTE Belite Bio, Inc
$151.66▲ +0.92%
Healthcare
Other
Volume 108.0K
Avg Volume (10D) 130.8K
Key Metrics & Fundamentals
Market Cap
$6.11B
P/E Ratio
–
Div Yield
0.00%
52W Range
97.99 - 200.00
% vs 50 MA
-7.01%
% vs 200 MA
-6.28%
RSI-14
45.1
MACD Histogram
+0.1200
Beta (1Y vs SPY)
1.06
Gross Rev
$0
Gross Profit
$0
EBITDA
-$34.91M
COGS
–
Operating Exp
$34.91M
Operating Income
-$34.91M
EBIT
-$34.91M
Pretax Income
-$28.36M
Net Income
-$28.41M
EPS (Diluted)
-0.70
Price & Volume History
Loading chart…
Recent News
Belite Bio Moves Listing to Nasdaq Global Select Market
MT Newswires · Oct 19, 2026 6:21 AM ET
Belite Bio Announces Uplisting to the Nasdaq Global Select Market
GlobeNewswire · Oct 19, 2026 6:00 AM ET
Belite Bio Stock In Focus After Stargardt Drug Filings In Three Markets
Simply Wall St. · Oct 17, 2026 6:13 AM ET
Belite Bio Submits Tinlarebant Applications in Three Markets for Rare Eye Disease
MT Newswires · Oct 14, 2026 4:33 PM ET
Belite Bio Announces Multi-Market Submission of Marketing Authorization Applications Via the Access Consortium Pathway for Tinlarebant for the Treatment of Stargardt Disease Type 1
GlobeNewswire · Oct 14, 2026 4:00 PM ET
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
GlobeNewswire · Oct 1, 2026 8:00 AM ET
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
GlobeNewswire · Sep 28, 2026 8:00 PM ET
Belite Bio Insider Sold Shares Worth $12,803,528, According to a Recent SEC Filing
MT Newswires · Sep 10, 2026 3:46 AM ET
Belite Bio, Inc. Sponsored ADR (BLTE)'s Technical Outlook is Bright After Key Golden Cross
Zacks · Sep 9, 2026 9:55 AM ET
Mizuho Raises Price Target on Belite Bio to $234 From $220, Keeps Outperform Rating
MT Newswires · Sep 9, 2026 7:09 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See BLTE's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.